Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PEN · against 143 other Healthcare companies of similar size
Ranked #104 of 144 · scores higher than 24% of peers
Bars: peers in each 10-point band of the valuation score25 peers with a valuation score of 40–49, including PEN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 142 reported | 1.3% | 2.7% | 31% | 30% | |
| EBITDA yieldHigher is better · 145 reported | 1.7% | 4.8% | 24% | 50% | |
| Free cash flow yieldHigher is better · 87 reported | 1.7% | 2.9% | 38% | 20% | |
| Book yieldHigher is better · 142 reported | 12.1% | 20.3% | 30% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 4 | 21.5B USD | 95 | 60 | |
| 104 | 7.7B USD | 41 | 37 | |
| 104 | 593.2B INR (≈$7.1B) | 41 | 47 | |
| 104 | 13.2B USD | 41 | 30 | |
| 104 | 10.8B USD | 41 | 41 | |
| 104 | 12.6B USD | 41 | 65 | |
| 110 | 7.3B USD | 40 | 74 | |
| 111 | 138.4B HKD (≈$17.7B) | 39 | 70 | |
| 111 | 9.4B USD | 39 | 70 | |
| 113 | 1.26T INR (≈$15.1B) | 38 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score